Vicryl Sutures: Why They Remain A Top Choice in General Surgery

By CN MEDITECH Editorial Team | Medical Device Manufacturing & Surgical Procurement Specialists

CN MEDITECH is a ISO 13485-certified manufacturer and global supplier of surgical sutures and wound closure products, serving hospitals, distributors, and medical laboratories across 60+ countries. Contact: meditech@cn-meditech.com

Vicryl sutures (polyglactin 910 suture) remain the most widely used absorbable suture material in general surgery worldwide — not because of inertia, but because decades of clinical evidence and consistent performance have earned them that position. For hospital procurement teams, surgical distributors, and laboratory evaluators sourcing absorbable sutures, understanding exactly why Vicryl continues to dominate purchasing decisions is essential to making informed procurement choices.

This article provides a clinically grounded, procurement-focused analysis of vicryl suture uses, material science, comparative performance, and documented limitations — everything a professional buyer or distributor needs to know.

 

1.Why Do Surgeons Still Prefer Vicryl Sutures?

Despite the introduction of newer absorbable materials over the past two decades, polyglactin 910 suture (commercially known as Vicryl, and available under equivalent generic formulations from manufacturers including CN MEDITECH) retains dominant market share in general and specialty surgery. The reasons are clinical, not commercial.

Superior Handling Characteristics

Vicryl's braided multifilament construction gives it exceptional pliability and softness in the surgeon's hands. Unlike stiffer monofilament alternatives, polyglactin 910 suture flows through tissue smoothly and can be manipulated easily in confined operative fields — a quality particularly valued in deep abdominal or pelvic procedures.

Per the United States Pharmacopeia (USP) and European Pharmacopoeia (Ph. Eur. 0324) standards governing synthetic absorbable sutures, polyglactin 910 must meet defined tensile strength retention thresholds: approximately 75% of original tensile strength at 2 weeks and 50% at 3 weeks post-implantation — a predictable degradation curve that surgeons and OR nurses have built clinical protocols around for over 40 years.

Knot Security

Braided construction is mechanically advantageous for knot holding. The interlocking fiber architecture creates higher knot security with fewer throws compared to monofilament sutures of equivalent gauge. This reduces operative time and the risk of knot slippage — a measurable safety advantage in high-tension closures such as fascial repair.

A 2003 comparative study published in The American Journal of Surgery (Trimbos et al.) confirmed that polyglactin 910 suture demonstrated statistically superior knot security versus comparable monofilament absorbables under simulated surgical conditions.

Flexibility Across Tissue Types

From delicate subcutaneous layers to robust fascial closures, vicryl sutures span USP sizes from 10-0 to #2, providing a single material solution across the majority of a hospital's soft tissue closure needs. This standardization benefits procurement teams: stocking a well-characterized suture across multiple sizes reduces vendor complexity and staff retraining.

Minimal Tissue Reaction

Polyglactin 910 hydrolyzes — it degrades by a predictable chemical process (hydrolysis of the ester linkage) rather than enzymatic degradation, which produces a significantly lower inflammatory response compared to natural absorbable sutures such as plain or chromic gut. The resulting tissue reaction is clinically manageable and well within accepted tolerances for most surgical applications.

This characteristic is documented in the peer-reviewed literature; a landmark study by Chu (1981) in Journal of Biomedical Materials Research established the hydrolysis mechanism of polyglactin 910, laying the scientific foundation for its clinical adoption.

Predictable Absorption Timeline

Complete absorption of polyglactin 910 occurs between 56 and 70 days (standard Vicryl) under normal physiological conditions. A coated variant absorbs within 42 days. This predictability allows surgeons to plan wound management timelines with confidence — a key requirement in postoperative protocols. Procurement professionals should note that absorption rate consistency is a key quality parameter to validate when qualifying generic polyglactin 910 suppliers.

For a comprehensive foundation on suture materials before diving deeper into vicryl-specific decisions, see CN MEDITECH's complete guide: Surgical Sutures — Everything You Need to Know

2.Common Surgical Uses of Vicryl Sutures

Understanding what vicryl suture is used for across specialties enables procurement teams to anticipate consumption patterns and distributors to advise clinical customers accurately. Polyglactin 910 suture is indicated across an exceptionally broad range of procedures.

Soft Tissue Closure

Vicryl is the benchmark material for layered soft tissue closure — subcutaneous fat, dermis, and fascial layers. Its combination of adequate tensile strength retention during the early healing phase, followed by gradual absorption, aligns with the biological timeline of wound healing. USP 2-0 and 3-0 sizes are the most frequently specified for general soft tissue applications.

Bowel Anastomosis and Gastrointestinal Surgery

In gastrointestinal surgery, polyglactin 910 suture is routinely used for bowel anastomosis — the reconnection of intestinal ends following resection. Its smooth passage through bowel wall tissue, combined with predictable tensile strength retention through the critical first three weeks of anastomotic healing, makes it a reliable choice for colorectal, small bowel, and gastric procedures.

Clinical guidelines from the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) and standard operative texts (Zollinger's Atlas of Surgical Operations, 9th ed.) reference polyglactin 910 as an appropriate material for gastrointestinal anastomoses. Hospital buyers supplying GI surgery departments should ensure consistent availability of USP 3-0 and 4-0 sizes with atraumatic needles.

Subcutaneous Tissue Approximation

Sub-cuticular and subcutaneous layer closure with vicryl sutures reduces dead space, minimizes fluid accumulation, and supports superficial wound integrity during the initial healing phase. Coated polyglactin 910 (Vicryl Rapide equivalent) is preferred in some wound types for its reduced surface friction and accelerated absorption.

Gynecology and Obstetrics

Vicryl sutures are among the most commonly used sutures in obstetric and gynecological surgery. Applications include:

· Cesarean section uterine closure (typically USP 1 or 0)

· Episiotomy repair

· Vaginal vault closure post-hysterectomy

· Ovarian cystectomy and adnexal surgery

A Cochrane Systematic Review (Kettle & Dowswell, 2010) comparing suture materials for perineal repair confirmed that polyglactin 910 was associated with less short-term pain compared to chromic catgut and demonstrated superior patient tolerance profiles.

Ligation of Vessels and Pedicles

Ligation — the tying off of blood vessels, ducts, or tissue pedicles to control bleeding or eliminate flow — is one of the most fundamental surgical techniques, and Vicryl sutures are among the most widely used materials for this purpose. The knot security and tensile retention of polyglactin 910 make it well-suited for ligation of small to medium vessels in both open and laparoscopic settings. For procurement buyers: free ties and ligating reels in USP 2-0 and 3-0 are high-volume SKUs in most OR supply chains.

Pediatric Surgery

In pediatric surgery, tissue fragility and the need for complete suture absorption (to avoid suture palpability or the need for removal under anesthesia) make polyglactin 910 a preferred choice. Fine gauge sizes (USP 4-0 to 6-0) are standard for neonatal and pediatric soft tissue procedures. Pediatric surgical centers represent an important procurement segment for distributors specializing in specialty hospital supply.

For guidance on selecting the correct suture gauge for specific procedures, refer to: Surgical Suture Sizes Explained — USP Standards Every Buyer Should Know

 

3.Vicryl vs Monocryl: What's the Difference?

The monocryl vs vicryl question is among the most frequently raised comparisons in surgical procurement and clinical selection discussions. Both are synthetic absorbable sutures, but they differ substantially in construction, behavior, and optimal application.

Key clinical takeaway: Vicryl excels in deep tissue applications requiring knot security and short-term tensile strength, while Monocryl (poliglecaprone 25) is preferred for superficial subcuticular closures where cosmesis and minimal tissue drag are prioritized.

For procurement purposes, these two sutures are complementary, not interchangeable — most surgical departments will stock both. Distributors advising OR procurement managers should position them as a paired solution covering the full spectrum of absorbable suture needs.

4.Limitations of Vicryl Sutures

A clinically credible evaluation of absorbable sutures must include a clear-eyed assessment of limitations. Procurement professionals and distributors who acknowledge these boundaries earn greater clinical trust — and source better-fitted product solutions.

Higher Tissue Drag

The braided multifilament surface of polyglactin 910 creates measurably greater tissue drag compared to monofilament sutures during passage. In superficial skin closures or delicate cosmetic procedures, this can result in microtrauma along the suture track. This is why Monocryl is preferred for cosmetic subcuticular closure and why many surgeons will use Vicryl Rapide (rapidly absorbing coated variant) rather than standard Vicryl for some superficial applications.

Not Ideal for Contaminated Wounds

Vicryl sutures are contraindicated in infected or heavily contaminated wound environments. The braided construction creates interstitial spaces that can harbor bacteria, potentiating infection and potentially contributing to suture sinus formation. In contaminated surgical fields — traumatic wounds, perforated viscus surgery, or grossly infected tissues — monofilament sutures (whether absorbable or non-absorbable) are the preferred choice.

This limitation is reflected in the ECRI Institute's Surgical Suture Product Guidance and is consistent with international surgical practice guidelines.

Bacterium Harboring Risk

Directly related to the contamination risk above: multifilament braided sutures can harbor bacteria more easily than monofilament sutures. Studies have demonstrated that Staphylococcus aureus and Escherichia coli adhere to braided suture surfaces at higher rates than to smooth monofilament surfaces. While Vicryl's polyglactin 910 coating reduces (but does not eliminate) this risk, surgical teams operating in contaminated fields should default to monofilament alternatives.

Moisture Sensitivity During Handling

Polyglactin 910 suture undergoes hydrolysis on contact with moisture — including intraoperative irrigation fluids and even surgical gloves dampened with saline. Prolonged pre-use exposure to moisture can degrade tensile strength prior to implantation. Storage and handling protocols (maintained in original packaging until use, stored per manufacturer conditions at 15–25°C, protected from humidity) are critical quality-control steps for both hospitals and distributors managing suture inventory. 

Understanding when to choose absorbable versus non-absorbable sutures for specific wound types is a core procurement competency — explore the full clinical decision framework at: Absorbable vs Non-Absorbable Sutures — A Clinical Guide to Choosing the Right Type

 

5.Regulatory and Quality Standards for Polyglactin 910 Sutures

Procurement teams and distributors qualifying vicryl suture suppliers must verify compliance with internationally recognized standards:

· USP <881> — Tensile Strength Testing for Absorbable Surgical Sutures

· ISO 10334:1994 — Specification for Absorbable Surgical Sutures

· European Pharmacopoeia (Ph. Eur.) Monograph 0324 — Synthetic Absorbable Braided Sutures

· ASTM F1452 — Standard Specification for Absorbable Multifilament Suture

Suture products should also be manufactured under ISO 13485 quality management systems and bear appropriate regulatory approvals (CE marking for European markets, FDA 510(k) clearance for US markets, NMPA registration for China).

CN MEDITECH's polyglactin 910 sutures are manufactured in an ISO 13485-certified facility and comply with the above standards, with full traceability documentation available for procurement audits.

6.FAQ About Vicryl Sutures

Is Vicryl suture absorbable?

Yes. Vicryl (polyglactin 910) is a synthetic absorbable suture. It degrades through hydrolysis — a reaction between the suture material and water present in body tissues. This process requires no enzymatic action, produces predictable byproducts (lactic and glycolic acids), and results in complete absorption within 56–70 days under normal physiological conditions.

How long does Vicryl last?

Vicryl sutures retain approximately 75% of their original tensile strength at 2 weeks and approximately 50% at 3 weeks. They are completely absorbed between 56–70 days. The rapidly absorbing variant (Vicryl Rapide equivalent) loses tensile strength faster, with complete absorption around 42 days — suitable for mucosal and superficial skin closures.

What is Vicryl made of?

Vicryl is made of polyglactin 910, a copolymer composed of 90% glycolide and 10% L-lactide. The braided suture is coated with a combination of polyglactin 370 and calcium stearate to reduce surface friction and improve handling. This synthetic composition is the foundation of its predictable absorption and low tissue reactivity.

Is Vicryl braided or monofilament?

Vicryl is a braided (multifilament) suture. Multiple fine polyglactin 910 fibers are woven together to form the suture strand. This construction gives Vicryl its characteristic knot security, pliability, and handling ease — but also contributes to its higher tissue drag and greater bacterial adherence risk compared to monofilament alternatives.

When should Vicryl not be used?

Vicryl sutures should not be used in the following situations:

· Infected or contaminated wounds — braided structure harbors bacteria

· Cardiovascular or neural tissue — not indicated; non-absorbable or specialized sutures are required

· Applications requiring long-term (>70 days) mechanical support — Vicryl will be fully absorbed before healing is complete in some tissues

· Patients with known hypersensitivity to polyglactin 910 or related materials

· Microsurgery — monofilament sutures are preferred for precision and minimal tissue reaction in ultra-fine gauge applications

Why do surgeons prefer Vicryl?

Surgeons prefer Vicryl for a combination of reasons: 40+ years of clinical validation, predictable absorption, excellent knot security, versatile sizing, broad applicability across surgical disciplines, and low inflammatory profile. The familiarity factor is also real — generations of surgeons have been trained with polyglactin 910 suture as their primary absorbable material, and its handling characteristics are well understood across OR teams worldwide. For procurement professionals, this translates into lower training burden, standardized protocols, and reduced clinical variation when switching to generic polyglactin 910 equivalents from qualified manufacturers.

 

7.Procurement Considerations for Distributors and Hospital Buyers

When sourcing polyglactin 910 suture from manufacturers other than the originator brand:

· Request tensile strength retention test data at 14 and 21 days, per USP <881> — this is the primary quality differentiator

· Verify absorption timeline documentation — complete absorption confirmation at 56–70 days under standardized conditions

· Confirm ISO 13485 certification and relevant market approvals (CE, FDA, NMPA, etc.)

· Review coating uniformity testing — uneven coating causes irregular tissue drag and can affect surgical feedback

· Assess packaging integrity — suture sterility depends on packaging maintained throughout the cold chain; request shelf-life validation data

· Evaluate needle attachment pull-out force — needle-suture junction failure is a documented quality issue in lower-grade products

CN MEDITECH offers full technical documentation packages for procurement qualification processes. Distributors and hospital procurement officers are encouraged to contact our technical sales team for samples, compliance documentation, and pricing.

 

8.Conclusion

Vicryl sutures — polyglactin 910 suture — remain a top choice in general surgery because they deliver consistent, evidence-backed performance across the full spectrum of soft tissue applications: from bowel anastomosis in gastrointestinal surgery, to ligation, pediatric procedures, and gynecological repair. Their knot security, predictable absorption, and low tissue reactivity are not marketing claims — they are properties established in peer-reviewed literature and validated by decades of global surgical practice.

For procurement teams and distributors, understanding both the clinical strengths and documented limitations of vicryl sutures — particularly the contraindication in contaminated wounds and higher tissue drag versus monofilament alternatives — enables smarter, more credible product recommendations and stronger supplier qualification decisions.